TY  - BOOK
AU  - Chothani, Ankit
TI  - Balloon mitral valvuloplasty in the United States: a 13-year perspective
SN  - 0002-9343
PY  - 2014///
KW  - *Balloon Valvuloplasty/ut [Utilization]
KW  - *Hospitalization/ec [Economics]
KW  - *Mitral Valve Stenosis/th [Therapy]
KW  - Age Distribution
KW  - Balloon Valvuloplasty/ae [Adverse Effects]
KW  - Balloon Valvuloplasty/ec [Economics]
KW  - Balloon Valvuloplasty/td [Trends]
KW  - Comorbidity
KW  - Continental Population Groups/sn [Statistics & Numerical Data]
KW  - Cross-Sectional Studies
KW  - Databases, Factual
KW  - Female
KW  - Hospital Mortality
KW  - Humans
KW  - Length of Stay/sn [Statistics & Numerical Data]
KW  - Length of Stay/td [Trends]
KW  - Male
KW  - Medicaid
KW  - Medicare
KW  - Middle Aged
KW  - Mitral Valve Stenosis/ep [Epidemiology]
KW  - United States/ep [Epidemiology]
KW  - MedStar Washington Hospital Center
KW  - Medicine/General Internal Medicine
KW  - Journal Article
N1  - Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - present
N2  - BACKGROUND: Incidence and prevalence of mitral stenosis is declining in the US. We performed this study to determine recent trends in utilization, complications, mortality, length of stay, and cost associated with balloon mitral valvuloplasty; CONCLUSIONS: In a large cross-sectional study of balloon mitral valvuloplasty in the US, we have reported trends of decreasing overall utilization and increasing procedural complication rates and cost over a period of 13 years.Copyright � 2014 Elsevier Inc. All rights reserved; METHODS: Utilizing the nationwide inpatient sample database from 1998 to 2010, we identified patients using the International Classification of Diseases, 9th Revision, Clinical Modification procedure code for "percutaneous valvuloplasty." Patients >18 years of age with mitral stenosis were included. Patients with concomitant aortic, tricuspid, or pulmonic stenosis were excluded. Primary outcome included death and procedural complications; RESULTS: A total of 1308 balloon mitral valvuloplasties (weighted n = 6540) were analyzed. There was a 7.5% decrease in utilization of the procedure from 24.6 procedures/10 million population in 1998-2001 to 22.7 procedures/10 million population in 2008-2010 (P for trend = .098). We observed a 15.9% overall procedural complication rate and 1.7% mortality rate. The procedural complication rates have increased in recent years (P = .001), corresponding to increasing age and burden of comorbidities in patients. The mean cost per admission for balloon mitral valvuloplasty has gone up significantly over the 10 years, from
UR  - http://dx.doi.org/10.1016/j.amjmed.2014.05.015
ER  -